1. Эндокринные заболевания как медико-социальная проблема современности / Е. В. Кузнецов [и др.] // Современные проблемы науки и образования. - 2017. - № 4. - С. 62.
2. Городецкая, И. В. Влияние йодсодержащих гормонов щитовидной железы на центральный отдел стресс- лимитирующей системы / И. В. Городецкая, Е. А. Гусакова // Вестн. ВГМУ. - 2018. - Т. 17, № 3. - С. 7-15.
3. Влияние глюкокортикоидов на морфологию и функцию щитовидной железы крыс / В. В. Виноградов [и др.] // Вес. Нац. акад. навук Беларусi. Сер. бiял. навук. - 2010. - № 3. - С. 87-93.
4. Stress and glucocorticoids increase transthyretin expression in rat choroid plexus via mineralocorticoid and glucocorticoid receptors / A. Martinho [at al.] // J. Mol. Neurosci. - 2012. - Vol. 48, N 1. - P. 1-13. https://doi.org/10.1007/s12031-012-9715-7
5. Sviridov, O. V. Interaction of thyroid hormones with immunoglobulins isolated from human blood serum. I. Parameters of complex formation and the nature of the binding reaction / O. V. Sviridov, M. N. Ermolenko // Biokhimiia. - 1994. - Vol. 59, N 1. - P. 78-87.
6. Immune regulation by glucocorticoids can be linked to cell type-dependent transcriptional responses / L. М. Franco // J. Exp. Med. - 2019. - Vol. 216, N 2. - P. 384-406. https://doi.org/10.1084/jem.20180595
7. Regulation of neuronal thyroid hormone receptor alpha 1 mRNA by hydrocortisone, thyroid hormone and retinoic acid / M. Satyanarayana [et al.] // Dev. Neurosci. - 1994. - Vol. 16, N 5-6. - P. 255-259. https://doi.org/10.1159/000112117
8. Thyroid hormone receptor beta1 gene expression is increased by dexamethasone at transcriptional level in rat liver / M. M. Montesinos [et al.] // Life Sci. - 2006. - Vol. 78, N 22. - P. 2584-2594. https://doi.org/10.1016/j.lfs.2005.10.019
9. Gil-Ibáñez, P. Hormone regulation of gene expression in primary cerebrocortical cells: Role of thyroid hormone receptor subtypes and interactions with retinoic acid and glucocorticoids / P. Gil-Ibáñez, J. Bernal, B. Morte // PLoS ONE. - 2014. - Vol. 9, N 3. - P. 91692. https://doi.org/10.1371/journal.pone.0091692
10. van der Geyten, S. Developmentally defined regulation of thyroid hormone metabolism by glucocorticoids in the rat / S. van der Geyten, V. M. Darras // J. Endocrinol. - 2005. - Vol. 185, N 2. - P. 327-336. https://doi.org/10.1677/joe.1.05974
11. Differential effects of maternal dexamethasone treatment on circulating thyroid hormone concentrations and tissue deiodinase activity in the pregnant ewe and fetus / A. J. Forhead [et al.] // Endocrinology. - 2007. - Vol. 148, N 2. - P. 800-805. https://doi.org/10.1210/en.2006-1194
12. Regulation of thyroid hormone availability by iodothyronine deiodinases at the blood-brain barrier in birds / C. H. Verhoelst [et al.] // Ann. NY Acad. Sci. - 2005. - Vol. 1040, N 1. - P. 501-503. https://doi.org/10.1196/annals.1327.103
13. Hernandez, A. Dexamethasone inhibits growth factor-induced type 3 deiodinase activity and mRNA expression in a cultured cell line derived from rat neonatal brown fat vascular-stromal cells / A. Hernandez, D. L. Germain // Endocrinology. - 2002. - Vol. 143, N 7. - P. 2652-2658. https://doi.org/10.1210/endo.143.7.8923
14. Kakucska, I. Qi. Changes in adrenal status affect hypothalamic thyrotropin-releasing hormone gene expression in parallel with corticotropin-releasing hormone / I. Qi. Kakucska, R. M. Lechan // Endocrinology. - 1995. - Vol. 136, N 7. - P. 2795-2802. https://doi.org/10.1210/endo.136.7.7789304
15. Glucocorticoids decrease thyrotropin-releasing hormone messenger ribonucleic acid expression in the paraventricular nucleus of the human hypothalamus / A. Alkemade [et al.] // J. Clin. Endocrinol. Metabol. - 2005. - Vol. 90, N 1. - P. 323-327. https://doi.org/10.1210/jc.2004-1430
16. Luo, L. G. Glucocorticoids stimulate thyrotropinreleasing hormone gene expression in cultured hypothalamic neurons / L. G. Luo, T. Bruhn, I. M. Jackson // Endocrinology. - 1995. - Vol. 136, N 11. - P. 4945-4950. https://doi.org/10.1210/endo.136.11.7588228
17. Dexamethasone rapidly regulates TRH mRNA levels in hypothalamic cell cultures: interaction with the cAMP pathway / L. Perez-Martinez [et al.] // Neuroendocrinology. - 1998. - Vol. 68, N 5. - P. 345-354. https://doi.org/10.1159/000054383
18. Benický, J. Effects of dexamethasone on pancreatic growth and thyroliberin (TRH) content in neonatal rat pancreas / J. Benický, V. Strbák // Physiol. Res. - 1995. - Vol. 44, N 3. - P. 165-172.
19. Dexamethasone treatment during pregnancy influences the number of TSH cells in rat fetuses / M. Manojlovic- Stojanoski [et al.] // Arch. Biol. Sci. - 2009. - Vol. 60, N 4. - P. 555-560. https://doi.org/10.2298/ABS0804555M
20. Dynamic changes of central thyroid functions in the management of Cushing’s syndrome / S. C. Dogansen [et al.] // Arch. Endocrinol. Metab. - 2018. - Vol. 62, N 2. - P. 164-171. https://doi.org/10.20945/2359-3997000000019
21. Diminished and irregular TSH secretion with delayed acrophase in patients with Cushing’s syndrome / F. Roelfsema [et al.] // Eur. J. Endocrinol. - 2009. - Vol. 161, N 5. - P. 695-703. https://doi.org/10.1530/EJE-09-0580
22. Primary thyroid disorders in endogenous Cushing’s syndrome / H. Niepomniszcze [et al.] // Eur. J. Endocrinol. - 2002. - Vol. 147, N 3. - P. 305-311. https://doi.org/10.1530/eje.0.1470305
23. Thyroid dysfunction in isolated adrenocorticotropic hormone (ACTH) deficiency: case report and literature review / T. Murakami [et al.] // Endocrinol. J. - 1993. - Vol. 40, N 4. - P. 473-478. https://doi.org/10.1507/endocrj.40.473
24. Tsigos, C. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress / C. Tsigos, G. P. Chrousos // J. Psychosom Res. - 2002. - Vol. 53, N 4. - P. 865-871. https://doi.org/10.1016/s0022-3999(02)00429-4
25. Giustina, A. The role of glucocorticoids in the regulation of growth hormone secretion. Mechanisms and clinical significance / A. Giustina, W. B. Wehrenberg // Trends Endocrinol. Metabol. - 1992. - Vol. 3, N 8. - P. 306-311. https://doi.org/10.1016/1043-2760(92)90142-N
26. Thyroid function in children with growth hormone (GH) deficiency during the initial phase of GH replacement therapy - clinical implications / J. Smyczynska [at al.] // Thyroid Res. - 2010. - Vol. 3, N 1. - P. 2. https://doi.org/10.1186/1756-6614-3-2
27. Keskin, M. Effects of 1-year growth hormone replacement therapy on thyroid volume and function of the children and adolescents with idiopathic growth hormone deficiency / M. Keskin, E. Bayramoglu, Z. Aycan // J. Pediatr. Endocrinol. Metab. - 2017. - Vol. 30, N 11. - P. 1187- 1190. https://doi.org/10.1515/jpem-2017-0210
28. An examination of the effects of different doses of recombinant human growth hormone on children with growth hormone deficiency / Y. Xue [et al.] // Exp. Ther. Med. - 2016. - Vol. 11, N 5. - P. 1647-1652. https://doi.org/10.3892/etm.2016.3091
29. Thyroid function in children with growth hormone deficiency during long-term growth hormone replacement therapy / Е. Witkowska-Sędek [et al.] // Cent. Eur. J. Immunol. - 2018. - Vol. 43, N 3. - P. 255-261. https://doi.org/10.5114/ceji.2018.80043
30. Investigation of the mechanisms contributing to the compensatory increase in insulin secretion during dexamethasoneinduced insulin resistance in rhesus macaques / B. P. Cummings [et al.] // J. Endocrinol. - 2013. - Vol. 216, N 2. - P. 207-215. https://doi.org/10.1530/JOE-12-0459
31. Somatostatin inhibits PC Cl3 thyroid cell proliferation through the modulation of phosphotyrosine phosphatase activity / T. Florio [et al.] // J. Biol. Chem. - 1996. - Vol. 271, N 11. - Р. 6129-6136. https://doi.org/10.1074/jbc.271.11.6129
32. Taton, M. Dissociation of the stimuli for cell hypertrophy and cell division in the dog thyrocyte: insulin promotes protein accumulation while TSH triggers DNA synthesis / M. Taton, J. E. Dumont // Exp. Cell Res. - 1995. - Vol. 221, N 2. - P. 530-533. https://doi.org/10.1006/excr.1995.1405
33. Insulin and TSH promote growth in size of PC Cl3 rat thyroid cells, possibly via a pathway different from DNA synthesis: comparison with FRTL-5 cells / T. Kimura [et al.] // Eur. J. Endocrinol. - 1999. - Vol. 140, N 1. - Р. 94-103. https://doi.org/10.1530/eje.0.1400094
34. Roelfsema, V. The growth hormone and insulin-like growth factor axis: its manipulation for the benefit of growth disorders in renal failure / V. Roelfsema, R. G. Clark // J. Am. Soc. Nephrol. - 2001. - Vol. 12, N 6. - P. 1297-1300.
35. Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors / J. E. Dumont [et al.] // Physiol Rev. - 1992. - Vol. 72, N 3. - P. 667-697. https://doi.org/10.1152/physrev.1992.72.3.667
36. Regulation of calcium-permeable TRPV2 channel by insulin in pancreatic-cells / E. Hisanaga [et al.] // Diabetes. - 2009. - Vol. 58, N 1. - P. 174-184. https://doi.org/10.2337/db08-0862
37. Translocation of a calcium-permeable cation channel induced by insulin-like growth factor-I / M. Kanzaki [et al.] // Nat. Cell Biol. - 1999. - Vol. 1, N 3. - Р. 165-170. https://doi.org/10.1038/11086
38. Insulin elicits a ROS-activated and an IP3-dependent Ca2+ release, which both impinge on GLUT4 translocation / A. Contreras-Ferrat [et al.] // J. Cell Sci. - 2014. - Vol. 127, N 9. - Р. 1911-1923. https://doi.org/10.1242/jcs.138982
Паслаць артыкул па эл. пошце 